Washington, DC, United States of America

Michael David Waud

This inventor holds 8 USPTO granted patents and 2 published patent applications. Top assignees: Kit Check, Inc., Bluesight, Inc.. Active years: 2015-2025.

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 6

Forward Citations = 91(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Biography of Michael David Waud

Introduction

Michael David Waud is an innovative inventor based in Washington, DC. He holds a total of 7 patents, showcasing his contributions to the field of medication tracking technology. His work focuses on improving the efficiency and accuracy of medication management systems.

Latest Patents

One of his latest patents involves a system and method for printing a label with an RFID tag. This system includes an RFID reader that queries a first RFID tag attached to a medicinal container. In response, the system receives a unique identifier to determine the medication's status, associate the container with a medical provider, and print a second label with a new RFID tag for another medicinal container.

Career Highlights

Throughout his career, Michael has worked with notable companies such as Kit Check, Inc. and Bluesight, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the healthcare technology sector.

Collaborations

Michael has collaborated with talented individuals, including Jennifer Ashley Gitchell and Timothy James Leo Kress-Spatz. These partnerships have contributed to the advancement of his projects and the successful implementation of his inventions.

Conclusion

Michael David Waud continues to make significant strides in the field of medication tracking technology. His dedication to innovation and collaboration positions him as a key figure in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…